Honda M, Kajikawa H, Kameoka H, Miyoshi S, Iwao N, Mizutani S
Jpn J Antibiot. 1985 Aug;38(8):2094-107.
The third part of our 3-years' continuous investigation on the clinical effect of cefaclor (CCL) against urinary tract infections was reported herein. CCL, a daily dose of 0.75 g t.i.d., has been applied for the treatment of (I) 69 cases with the uncomplicated acute cystitis in the women, and (II) 44 cases with the complicated. Rates of effectiveness obtained were 94.2% in (I), which was a little lower than the first or the second part of our report, and 70.5% in (II), which equaled the mean value of our first and second reports. Any definite difference was not obtained between the effectiveness rates in those who had ever been treated with CCL and those who not, in both (I) and (II) groups.
本文报道了我们对头孢克洛(CCL)治疗尿路感染临床疗效进行的为期3年的连续研究的第三部分。CCL每日剂量为0.75g,每日3次,已用于治疗:(I)69例非复杂性急性膀胱炎女性患者;(II)44例复杂性患者。(I)组有效率为94.2%,略低于我们报告的第一部分或第二部分;(II)组有效率为70.5%,与我们第一和第二份报告的平均值相当。在(I)组和(II)组中,曾接受CCL治疗的患者与未接受CCL治疗的患者的有效率之间未发现任何明显差异。